Navigation Links
H2O - a cure for low blood pressure

US researchers have found that a large glass of water may be the latest blood pressure drug for some patients.

Investigators at Vanderbilt's Autonomic Dysfunction Center reported that water has a powerful blood pressure raising effect in patients who experience fainting spells while standing.//

Blood pressure started increasing within two or three minutes after the water was ingested, increased rapidly over the next 15 minutes, and then began to decrease after about 60 minutes. Drinking more water at 60 minutes caused the blood pressure effect to be sustained for another hour.

"There is something about the water itself that causes the increase in blood pressure; intravenous infusion of 475 millilitres of sugar solution did not elicit the effect.

Water might be increasing blood pressure by interacting with osmoreceptors (which sense salt concentrations) or stretch receptors in the stomach or liver," added Jordan, the director of the Clinical Research Center at the Franz University in Germany.


'"/>




Page: 1

Related medicine news :

1. Infant receives first bloodless liver transplant
2. Spouses and other partners lower blood pressure says new research
3. Uncontrolled blood pressure
4. Nitric oxide involved in high blood pressure
5. Recouping blood flow after a stroke
6. Way to monitor blood pressure
7. Drugs disrupt formation of blood vessels
8. Gene therapy - Aim to improve blood flow
9. New Drug ALT-711 decreases blood vessel stiffness
10. Aggressive blood pressure treatment needed
11. Borderline blood pressure- possible health risk

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: cure for low blood pressure

(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center,...s , is one of a growing number of physicians who a...sites to connect with individuals who are interest...id obesity. Dr. Kim is utilizing Facebook to share... practice with the community. , ...
(Date:11/25/2009)...o.,Nov.25/PRNewswire/--TheBartleHallConventionCent...iniconDec.9-10,whenKansasCityhoststhelatestinaseri...hisfreecliniceventhasthepotentialtobethebiggestone...andbeheldonweekdaysinsteadofoveraweekend,"SheriWoo...andpresidentoftheNationalAssociationofFreeClinics(...
(Date:11/25/2009)...,Md.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJan...luationandResearch,titled"ADifficultBalance-PainMa...2009issueofTheNewEnglandJournalofMedicine. ,, (.../FDALOGO ) ,, Inthearticle,WoodcockdiscussesFDA...onforthosewhoneeditandmanagingtherisksposedbyvario...
(Date:11/25/2009)...ound evidence of a statistically significant survi... whose estrogen receptor (ER)-positive tumors had ...ine-118 (ER-alpha S118-P), according to a brief co...ournal of the National Cancer Institute . , Appr...o tamoxifen. Preclinical studies have shown that E...
(Date:11/25/2009)... Evaluation and treatment clinics to resume M...k (Vocus) November 25, 2009 -- Centegra Health Sys... H1N1 vaccine shots at four Centegra Primary Care ...f vaccine has arrived. The clinics are at CPC site...and will be open as follows: ,   From ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...s Ability to Treat Subcutaneous Infections , , EM..., Inc. (NYSE Alternext: NBY), a clinical stage bio...reclinical data related to NVC-422, the lead molec...an Francisco during March 6-10, 2009. NovaBay is ...
...evier,world-leading publisher of scientific, techn..., is pleased to announce the July 2009 launch of a...with the American College of,Osteopathic Family Ph...sicians, is designed to deliver information that h...
...k logged on to www.WorldMedAssist.com to help hi...recommended. Just three weeks later, he was out o...ompleted. He,s now home and enjoying his new leas...em with his heart,s mitral valve, he had no idea h...
...ded family law attorney among just five percent of...s professional designation , ...ruce Chase , a respected Hackensack, N.J. attorney...wyers magazine as one of the top attorneys in the ...
...ations of pharmaceutical drugs and endocrine-disru... are likely too low to impact human health, accord...on, the nation,s leading drinking water research o...nds found in our public drinking water are likely ...
...ical cancer may direct more women to optimal thera...m morbidity and complications of trimodality thera... to a study performed at the Institute for Technol...t imaging with MRI and/or PET/CT in patients with ...
Other Medicine News:Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 3Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 2Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 3Health News:Ohio Patient Thanks India and WorldMed Assist For Heart Surgery Overseas; His Indian Surgeon Thanks U.S. for Superb Training 2Health News:Ohio Patient Thanks India and WorldMed Assist For Heart Surgery Overseas; His Indian Surgeon Thanks U.S. for Superb Training 3Health News:Hackensack Lawyer Bruce E. Chase Named New Jersey Super Lawyer for Third Consecutive Year 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 3Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 4Health News:MRI and PET/CT improve cervical cancer patient's chances for optimal treatment 2
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...OandSTAFA,Switzerland,Nov.25/PRNewswire/-- FromNov...vehearingsolutions,presentedthesecondeditionoftheH...needsoftheolderpopulation.Theconferencebroughttoge...worldandmorethan250clinicianswhoworkeverydaywithol...eriencesanddiscussthelatestresearchandtrendsinhear...
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 5873 1PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 5873 2Warner Chilcott Completes Acquisition of P 26amp 3BGs Global Branded Prescription Pharmaceuticals Business 5871 1Warner Chilcott Completes Acquisition of P 26amp 3BGs Global Branded Prescription Pharmaceuticals Business 5871 2NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 1NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 2NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 3NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 4
...ne, Inc. (NYSE Amex: PIP ), a biodefense company...ical and chemical threats, announced today that ne...esented at the Keystone Symposia on Molecular and ...rch 29-April 3, 2009 in Banff, Alberta. , , The...or of Medicine and Dr. Subhendu Basu, Research Ass...
...Rx Pharmaceuticals, a privately-held biopharmaceut...d enrollment in the Company,s second pivotal Phase...ets). Together with the previously completed first...y has fully enrolled its planned pivotal Phase 3 s...n-free oral therapy currently in development for t...
Other Medicine Technology:Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 2Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 3Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 4Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 5Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 6QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3
AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)
AST-GOT
...-line worker" for routine staining protocols frequ...s. It automatically stains big quantities of slide...of reagent stations in combination with a continuo...p to 12 baskets with 30 slides each can be process...
MS/DS 50/100 Slide Stainer
Medicine Products: